Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study von Castagna, Antonella, Maggiolo, Franco, Penco, Giovanni, Wright, David, Mills, Anthony, Grossberg, Robert, Molina, Jean-Michel, Chas, Julie, Durant, Jacques, Moreno, Santiago, Doroana, Manuela, Ait-Khaled, Mounir, Huang, Jenny, Min, Sherene, Song, Ivy, Vavro, Cindy, Nichols, Garrett, Yeo, Jane M.

Volltext

Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects von Brothers, Cindy H, Hernandez, Jaime E, Cutrell, Amy G, Curtis, Lloyd, Ait-Khaled, Mounir, Bowlin, Steve J, Hughes, Sara H, Yeo, Jane M, Lapierre, Didier H

Volltext

Warfarin Poisoning and Blunt Abdominal Trauma: A Rare Cause of Small Bowel Obstruction von Yeo, Jane H, Terez, Claire, Shapiro, Michael, Merchant, Aziz

Volltext

Lean Lobectomy: Streamlining Video-Assisted Lobectomy to Increase the Value of Lung Cancer Care von Yeo, Jane H., Shariati, Nazly M., Pelz, Geoffrey B., Dozier, Jordan M., Rizk, Nabil P.

Volltext

Signs and Symptoms of Venous Thromboembolism and Survival Outcome of Endometrial Cancer von Machida, Hiroko, Hom, Marianne S, Maeda, Midori, Yeo, Jane J, Ghattas, Christian S, Grubbs, Brendan H, Matsuo, Koji

Volltext

Emergence of Resistance to Protease Inhibitor Amprenavir in Human Immunodeficiency Virus Type 1-Infected Patients: Selection of Four Alternative Viral Protease Genotypes and Influe... von MAGUIRE, Michael, SHORTINO, Denise, PARKER, Hayley, MAY, Jackie, SNOWDEN, Wendy, KLEIN, Astrid, HARRIS, Wendy, MANOHITHARAJAH, Varsha, TISDALE, Margaret, ELSTON, Robert, YEO, Jane, RANDALL, Sharon, FAN XU

Volltext

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study von Eron, Joseph J., Clotet, Bonaventura, Durant, Jacques, Katlama, Christine, Kumar, Princy, Lazzarin, Adriano, Poizot-Martin, Isabelle, Richmond, Gary, Soriano, Vincent, Ait-Khaled, Mounir, Fujiwara, Tamio, Huang, Jenny, Min, Sherene, Vavro, Cindy, Yeo, Jane

Volltext

Six-Week Randomized Controlled Trial To Compare the Tolerabilities, Pharmacokinetics, and Antiviral Activities of GW433908 and Amprenavir in Human Immunodeficiency Virus Type 1-Inf... von WOOD, Robin, ARASTEH, Keikawus, NADERER, Odin J, STELLBRINK, Hans-Jürgen, TEOFILO, Eugenio, RALLI, Francois, POLLARD, Richard B, ERON, Joseph, YEO, Jane, MILLARD, Judith, WIRE, Mary Beth

Volltext

Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial von Paton, Nicholas I, Gurumurthy, Meera, Lu, Qingshu, Leek, Francesca, Kwan, Philip, Koh, Hiromi W L, Molton, James, Mortera, Lalaine, Naval, Sullian, Bakar, Zamzurina Abu, Pang, Yong-Kek, Lum, Lionel, Lim, Tow Keang, Cross, Gail B, Lekurwale, Ganesh, Choi, Hyungwon, Au, Veonice, Connolly, John, Hibberd, Martin, Green, Justin A

Volltext

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomi... von Eron, Joseph, Yeni, Patrick, Gathe, Joseph, Estrada, Vicente, DeJesus, Edwin, Staszewski, Schlomo, Lackey, Philip, Katlama, Christine, Young, Benjamin, Yau, Linda, Sutherland-Phillips, Denise, Wannamaker, Paul, Vavro, Cindy, Patel, Lisa, Yeo, Jane, Shaefer, Mark

Volltext

A 42-Week Open-Label Study to Assess the Pharmacokinetics, Antiretroviral Activity, and Safety of Amprenavir or Amprenavir plus Ritonavir in Combination with Abacavir and Lamivudin... von Wood, Robin, Eron, Joseph, Arasteh, Keikawus, Teofilo, Eugenio, Trepo, Christian, Livrozet, Jean-Michel, Yeo, Jane, Millard, Judith, Wire, Mary Beth, Naderer, Odin J.

Volltext

SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients von GATHE, Joseph C, IVE, Prudence, WOOD, Robin, SCHÜRMANN, Dirk, BELLOS, Nicholaos C, DEJESUS, Edwin, GLADYSZ, Andrzej, GARRIS, Cindy, YEO, Jane

Volltext

Abacavir and the potential risk of myocardial infarction von Cutrell, Amy, Brothers, Cindy, Yeo, Jane, Hernandez, Jamie, Lapierre, Didier

Volltext

Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry von Lok, Sheau Wen, Tung, Iris, Anton, Angelyn, Baron-Hay, Sally E., De Boer, Richard H., Boyle, Frances M., Collins, Ian M., Cuff, Katharine, Gately, Lucy, Georgiou, Chloe L., Greenberg, Sally, Karki, Bhaskar, Nott, Louise M., Nottage, Michelle K., Rainey, Natalie, Torres, Javier, Yeo, Belinda Jane, Gibbs, Peter, Wong, Vanessa

Volltext

The Beck Inventory--hidden cost von Yeo, Jane

Volltext

Long-Term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: An uncontrolled, open-label, single-a... von Gathe, Joseph C., Wood, Robin, Sanne, Ian, Dejesus, Edwin, Dirk, Schürmann, Gladysz, Andrzej, Garris, Cindy, Givens, Naomi, Elston, Robert, Yeo, Jane

Volltext

Fosamprenavir/ritonavir in advanced HIV disease (TRIAD): a randomized study of high-dose, dual-boosted or standard dose fosamprenavir/ritonavir in HIV-1-infected patients with anti... von Molina, Jean-Michel, Ait-Khaled, Mounir, Rinaldi, Roberto, Penco, Giovanni, Baril, Jean-Guy, Cauda, Roberto, Soriano, Vicente, Pialoux, Gilles, Wire, Mary Beth, Lou, Yu, Givens, Naomi, Craig, Charles, Nichols, W. Garrett, Barbosa, Inês, Yeo, Jane

Volltext

Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection von Pedneault, Louise, Brothers, Cindy, Pagano, Grace, Tymkewycz, Paulina, Yeo, Jane, Millard, Judith, Fetter, Anny

Volltext

The Beck Inventory--hidden cost von Jenkins, Graham Curtis

Volltext

The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex : a double-blind, randomized trial von COOPER, D. A, PEHRSON, P. O, FARTHING, C, DOHERTY, R, YEO, J. M, PEDERSEN, C, MORONI, M, OKSENHENDLER, E, ROZENBAUM, W, CLUMECK, N, FABER, V, STILLE, W, HIRSCHEL, B

Volltext